RVMD · Healthcare · $43.8B
After-hours $206.02+0.06%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 464 Biotechnology peers
“매출은 최근 네 분기 연속 0달러로 아직 제품 판매 단계에 들어서지 못했지만, 임상과 출시 준비는 크게 가속됐어요.”
In the company's words · 2026 2분기 earnings call